IRHYTHM TECHNOLOGIES INC
NASDAQ: IRTC (iRhythm Holdings, Inc.)
Last update: 9 hours ago108.11
0.76 (0.70%)
| Previous Close | 107.35 |
| Open | 109.00 |
| Volume | 544,314 |
| Avg. Volume (3M) | 523,361 |
| Market Cap | 3,552,590,848 |
| Price / Earnings (Forward) | 769.23 |
| Price / Sales | 4.47 |
| Price / Book | 22.29 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2026 |
| Profit Margin | -15.90% |
| Operating Margin (TTM) | -19.49% |
| Diluted EPS (TTM) | -3.12 |
| Quarterly Revenue Growth (YOY) | 20.30% |
| Total Debt/Equity (MRQ) | 848.67% |
| Current Ratio (MRQ) | 5.71 |
| Operating Cash Flow (TTM) | 47.53 M |
| Levered Free Cash Flow (TTM) | 26.95 M |
| Return on Assets (TTM) | -4.37% |
| Return on Equity (TTM) | -111.13% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | iRhythm Holdings, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | 1.5 |
| Price Volatility | 4.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.5 |
| Average | 1.20 |
|
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 1.08% |
| % Held by Institutions | 115.08% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Holocene Advisors, Lp | 31 Mar 2026 | 1,248,658 |
| Eventide Asset Management, Llc | 31 Mar 2026 | 760,825 |
| 52 Weeks Range | ||
| Median | 214.00 (97.96%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 11 Mar 2026 | 214.00 (97.96%) | Buy | 119.64 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BAIREY MERZ CATHLEEN NOEL | 111.39 | - | 1,573 | 175,216 |
| BLACKFORD QUENTIN S. | 113.90 | - | 178 | 20,274 |
| BODAKEN BRUCE G. | 111.39 | - | 1,573 | 175,216 |
| FREEMAN SEAN CLINTON | 113.90 | - | 273 | 31,095 |
| LING KAREN | 111.39 | - | 1,573 | 175,216 |
| MCGINNIS KAREN K | 111.39 | - | 1,573 | 175,216 |
| OBOYLE KEVIN C | 111.39 | - | 1,573 | 175,216 |
| PATTERSON CHAD | 113.90 | - | 177 | 20,160 |
| ROSENBAUM MARC WADE | 113.90 | 105.50 | -551 | -56,635 |
| SHRISHRIMAL SUMI | 113.90 | 105.50 | -1,583 | -165,889 |
| TALWALKAR ABHIJIT Y | 111.39 | - | 1,573 | 175,216 |
| TURAKHIA MINANG | 113.90 | - | 137 | 15,604 |
| YOOR BRIAN B | 111.39 | - | 1,573 | 175,216 |
| Aggregate Net Quantity | 9,642 | |||
| Aggregate Net Value ($) | 1,091,124 | |||
| Aggregate Avg. Buy ($) | 112.55 | |||
| Aggregate Avg. Sell ($) | 105.50 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ROSENBAUM MARC WADE | Officer | 02 Jun 2026 | Sell (-) | 729 | 105.50 | 76,910 |
| SHRISHRIMAL SUMI | Officer | 02 Jun 2026 | Sell (-) | 1,716 | 105.50 | 181,038 |
| BLACKFORD QUENTIN S. | Officer | 29 May 2026 | Acquired (+) | 178 | 113.90 | 20,274 |
| FREEMAN SEAN CLINTON | Officer | 29 May 2026 | Acquired (+) | 273 | 113.90 | 31,095 |
| PATTERSON CHAD | Officer | 29 May 2026 | Acquired (+) | 177 | 113.90 | 20,160 |
| TURAKHIA MINANG | Officer | 29 May 2026 | Acquired (+) | 137 | 113.90 | 15,604 |
| ROSENBAUM MARC WADE | Officer | 29 May 2026 | Acquired (+) | 178 | 113.90 | 20,274 |
| SHRISHRIMAL SUMI | Officer | 29 May 2026 | Acquired (+) | 133 | 113.90 | 15,149 |
| YOOR BRIAN B | Director | 27 May 2026 | Acquired (+) | 1,573 | 111.39 | 175,216 |
| TALWALKAR ABHIJIT Y | Director | 27 May 2026 | Acquired (+) | 1,573 | 111.39 | 175,216 |
| OBOYLE KEVIN C | Director | 27 May 2026 | Acquired (+) | 1,573 | 111.39 | 175,216 |
| MCGINNIS KAREN K | Director | 27 May 2026 | Acquired (+) | 1,573 | 111.39 | 175,216 |
| LING KAREN | Director | 27 May 2026 | Acquired (+) | 1,573 | 111.39 | 175,216 |
| BODAKEN BRUCE G. | Director | 27 May 2026 | Acquired (+) | 1,573 | 111.39 | 175,216 |
| BAIREY MERZ CATHLEEN NOEL | Director | 27 May 2026 | Acquired (+) | 1,573 | 111.39 | 175,216 |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |